[PA2600067] Tender for 1 Smart Uroflowmeter

Auto-translated from Chinese

Original title: [PA2600067] 智慧型尿流儀1台招標案

國立臺灣大學醫學院附設醫院癌醫中心分院

Published: Jun 18, 2026

Updated: Jun 25, 2026

Source: taiwan_pcc

This tender has expired

The submission deadline for this tender has passed. It is no longer accepting bids.

Browse open Health & Medical tenders in Taiwan

About This Opportunity

This is a supplies contract in the health and medical services and general supplies sectors, with a focus on Medical Equipment and Pharmaceuticals. Located in Taiwan, Asia, this opportunity is open to firms and consortiums, with an estimated budget of TWD 910,000. Proposals must be submitted before June 23, 2026.

Published through Taiwan PCC e-Procurement, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

Original language: Chinese

This tender, reference PA2600067, is a public call for quotations or proposals for the procurement of one unit of a smart uroflowmeter. The contracting authority is the National Taiwan University Hospital Cancer Center Branch. The procurement nature is classified as goods, with an estimated budget of NT$910,000. This tender seeks advanced medical diagnostic equipment used for assessing bladder function and urine flow. Typical requirements for such medical equipment include high accuracy and reliability, compliance with medical device standards, user-friendly interface, data management capabilities (e.g., electronic health record integration), and comprehensive after-sales support including calibration and maintenance. Bidders are expected to provide detailed technical specifications, performance data, software compatibility information, warranty terms, and training for medical staff. The procurement aims to enhance diagnostic capabilities within the hospital's urology or related departments.

Data provenance

This notice is sourced from Taiwan PCC e-Procurement and was originally published on June 18, 2026. Last refreshed today. Original language: Chinese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About 國立臺灣大學醫學院附設醫院癌醫中心分院

國立臺灣大學醫學院附設醫院癌醫中心分院 has issued 91 procurement notices on BidsFactory, including 11 currently open and 0 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Information & Communication Technology. All notices are published for Taiwan. Notices are distributed via Taiwan PCC e-Procurement. Most recent publication: June 18, 2026.

Frequently asked questions about this tender

How can I submit a bid?

Visit Taiwan PCC e-Procurement to access the full notice, required documents, and submission instructions provided by the contracting authority.

When does this tender close?

The submission deadline is June 23, 2026. Proposals must be received by the contracting authority before that date.

Who is the contracting authority?

This notice was issued by 國立臺灣大學醫學院附設醫院癌醫中心分院 in Taiwan. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

What is the estimated budget?

The estimated contract value is NT$910,000 - NT$910,000. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.

Where will the contract be performed?

The contract is for delivery in Taiwan. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.